Analysis of a capsid-modified and conditionally replicating, oncolytic adenoviral vector as a novel treatment for human glioblastoma multiforme.
Glioblastoma multiforme (GBM) is the most aggressive brain tumor, and patients rarely survive for more than 2 years. Gene therapy may offer new treatment options and improve the prognosis for patients with GBM. Adenovirus-mediated gene therapy strategies for brain tumors have been limited by ineffic...
Tallennettuna:
Päätekijä: | |
---|---|
Muut tekijät: | |
Aineistotyyppi: | Dissertation |
Kieli: | englanti |
Julkaistu: |
Philipps-Universität Marburg
2010
|
Aiheet: | |
Linkit: | PDF-kokoteksti |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
PDF-kokotekstiHyllypaikka: |
urn:nbn:de:hebis:04-z2010-06444 |
---|---|
Julkaisupäivä: |
2010-12-02 |
Lähde: |
A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Cancer Res. 2007 Sep 15;67(18):8783-90. PMID: 17875719 |
Datum der Annahme: |
2010-07-08 |
Downloads: |
38 (2024), 75 (2023), 100 (2022), 124 (2021), 72 (2020), 93 (2019), 48 (2018) |
Lizenz: |
https://rightsstatements.org/vocab/InC-NC/1.0/ |
Linkki aineistoon: |
https://archiv.ub.uni-marburg.de/diss/z2010/0644 https://doi.org/10.17192/z2010.0644 |